+44 1223 790975
+44 1223 790975
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 4334 citations as per Google Scholar report
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
| Journal total citations count | 4334 |
| Journal impact factor | 2.04 |
| Journal 5 years impact factor | 3.14 |
| Journal cite score | 10.01 |
| Journal h-index | 25 |
| Journal h-index since 2019 | 22 |
 |
The influence of vinpocetine alone or in combination with Epigallocatechin-3-gallate, Coenzyme COQ10, Vitamin E and Selenium as a potential neuroprotective combination against aluminium-induced Alzheimer's disease in Wistar Albino Rats |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Clitoria ternatea Mediated Synthesis of Graphene Quantum Dots for the Treatment of Alzheimerâs Disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Diabetes as a risk factor for Alzheimerâs disease in the Middle East and its shared pathological mediators |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Genetic determinants of obesity heterogeneity in type II diabetes |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Gene Expression Pattern of PI3K/AKT Pathway Based on Insulin Resistance and Vitamin D Toward the Understanding of T2DM Pathogenesis |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Safety considerations when using non-ergot dopamine agonists to treat Parkinsonâs disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Review on Elderly Obese People |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Caffeine induces neurobehavioral effects through modulating neurotransmitters |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Factorâs Associated with Type 3 Diabetes and Type 2 Diabetes |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Altered insulin pathway compromises mitochondrial function and quality control both in in vitro and in vivo model systems |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-?4âassociated Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimerâs Disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Important advances in Alzheimerâs disease from the use of induced pluripotent stem cells |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Telmisartan Activates PPAR? to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in MiceYingxiao |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Recent Insights on the Role of PPAR??/? in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease |
| View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
